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Background:Oxidative stress in hepatitis C patients has been linked to hepatitis C virus.We veriﬁed this assump-
tion in HCV genotype 3 patients by detecting the relationship between viral load and certain speciﬁc oxidative
stress markers like Cu, Mn, Fe, Se, Zn and glutathione and glutathione-dependent enzymes.
Method: Subjects (n= 200, average age 24 years)with quantitative HCV RNA polymerase chain reaction-proven
genotype 3 hepatitis C were simultaneously evaluated. Cu, Mn, Fe, Se and Zn serum levels were by using atomic
absorption spectrophotometer. Internationally accepted methods were used for viral load quantiﬁcation of
glutathione, GR and Gpx serum levels.
Result: There was a signiﬁcant correlation between HCV viral load and studied parameters. With the increase of
viral load from mild group (200,000–1,000,000 copies/ml) to severe group (5,000,000–25,000,000 copies/ml)
the serum levels of Cu, Mn, Zn, and Fe and glutathione reductase were found to be abnormally high. However,
in severe viral load group serum concentration of Se and glutathione was less than the healthy controls.
Conclusion: As a signiﬁcant correlation was detected between the study parameters in genotype 3 HCV patients,
it is concluded that the studied micronutrients and glutathione and glutathione-dependent enzymes are the
biomolecular targets of HCV to induce oxidative stress.
General signiﬁcance: Constant monitoring and regulation of the recommended biomolecular targets of HCV can
improve the plight of more than 170 million patients suffering from hepatitis C virus around the globe.© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Worldwide 170million individuals are estimated to be infectedwith
hepatitis C virus [1]. It is one of the fourmost prevalent health problems
globally and it leads to liver injury, cirrhosis, hepatocellular carcinoma
and eventually to the death of affected patients. Hepatitis C virus is
thought to be the second most common cause of hepatitis worldwide.
The prevalence of HCV infection varies throughout the world. Unlike
thedeveloped country as theUnited States, the frequent source of trans-
mission of HCV in developing countries is exposure to infected blood in
healthcare and community settings [2–4].
In hepatitis C the patient faces different stages of infection. Acute
hepatitis C is an initial stage marked by the appearance of HCV RNA in
serum within 1 to 2 weeks of exposure and it is also accompanied by
elevation in serum alanine aminotransferase (ALT) levels, and then
jaundice. Antibody to HCV (anti-HCV) tends to appear late. Acute
hepatitis is curable by medication. However, 55% to 85% of patients do
not clear virus, and develop chronic hepatitis C. The chronic progressionq).
. This is an open access article underof hepatitis C involves progressive hepatic ﬁbrosis, cirrhosis, and
hepatocellular carcinoma [5].
Moreover, the entry of HCV virus in the cell is mediated by several
receptors and co-receptors like CD81, occludin, claudin-1 and scavenger
receptor class B type I [6]. The complex of enveloped nuclear capsid, apo
E and VLDL act as LDL receptor ligand and binds to the surface receptor
and enters the hepatocyte by internalization [7]. An internal ribosomal
entry site situated inside the 5′ UTR is utilized for the translation of
positive-sense HCV RNA [8].
After the entry of virus in the body the process of HCV replication
starts and all the structural and non-structural components of HCV
genome are associated with its replication. The length of HCV ge-
nome is 9.6 kb and it consists of three main regions. These are struc-
tural region with three genes (C, E1, E2), nonstructural region (p7,
NS2, NS3, NS4A/B, NS5A/B) and the protein coding regions, ﬂanked
by UTRs at 5′ and 3′. The structural genes code for the core protein
which makes the viral capsid and envelope glycoprotein. Nonstruc-
tural genes (NS2, NS3, NS4A/B, NS5A/B) and p7, an essential mem-
brane protein that works as an ion channel, are involved in viral
replication, poly-protein processing, and/or morphogenesis and viral
release. The 5′ and 3′ UTRs are necessary for the expression andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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tail of 98-nucleotide sequence downstream at the 3′ terminus of the ge-
nome. The 3′ tail of HCV with the nucleotide sequence is highly con-
served. This highly conserved tail is present in whole HCV genome.
This 3′ tail is very crucial for the initiation of replication of genome
and the whole process of HCV replication is only dependent on the
HCV genome [9–11].
However, according to some recent studies the process of HCV
replication is affected by external factors like reactive oxygen spe-
cies at a subcellular level. In hepatitis C patients, a state of oxidative
stress is acquired by the body cell. In this process the equilibrium
between the oxidant and antioxidant production is lost in the
body and it leads to overproduction of reactive oxygen species
[12]. Overproduction of ROS causes oxidative stress resulting in
cellular damage which leads to a more free radical production
[13]. In HCV patients ROS mainly originated from liver Kupffer
and inﬂammatory cells producing weak immune response [14,
15]. HCV core protein and NS proteins are reported to increase
the production of ROS in the body and these proteins also interferes
with normal working of cells by inhibiting electron transport chain,
altering apoptosis, transcription process and cell signaling [16].
These malicious proteins further alter the level of endogenous anti-
oxidants and anti-oxidant enzymes in the body [17]. NS proteins,
particularly NS5A and NS3 are the major replication complexes
and the ROS that are generated as a result of hepatitis C infection
also attacks on these active HCV replication complexes and reduces
the amount of NS3 and NS5A which results in the suppression of
HCV RNA replication in human hepatoma cells [18]. So HCV replica-
tion is not beneﬁted by the overproduction of ROS.
Along with signal transduction, HCV RNA replication suppression
and gene regulation free radicals also play a role as toxins in the
human body [19]. After exposure to HCV, the diseased liver produces
excessive amount ROS from internal sources like mitochondria, inﬂam-
matory cells and peroxisomes [20]. In liver disease, themain sources re-
sponsible for the overproduction of ROS are endogenous sources such as
the mitochondrial factor, peroxisomes, and activated inﬂammatory
cells. These radicals damage cells by attacking vital cell components,
such as the fat and protein constituents of the cell wall and the cell's
genetic material. For instance, oxidative stress can induce enhanced
metabolism of fat molecules (i.e., lipid peroxidation) that may generate
biologically active molecules. Some of these molecules sometimes
contribute to the development of ﬁbrosis. However, the formation of
oxygen radicals is a natural process and this occurs during numerous
metabolic processes [21].
ROS acts as potential carcinogens that facilitate mutagenesis,
tumor progression and tumor promotion, by having an effect on
the redox-responsive signaling cascades. Therefore, enhanced
ROS generation by HCV virus infection can cause enhanced oxida-
tive stress that leads to activation of oncogenic transcription fac-
tors that ultimately ends at hepatocellular carcinoma. Two
Transcription Factors, NF-кB (nuclear factor к B) and AP-1 (Activa-
tor protein 1), are activated as a result of oxidative stress to the
cells. Also, the two distinct protein Families namely, i) MAPK (Mi-
togen Activated Protein Kinases) and ii) The Redox Sensitive Ki-
nases regulates the signal transduction pathways activated by
ROS. Mitochondrial ROS are also generated by HCV RNA genome.
The HCV non-structural protein 5A (NS5A) is associated with endo-
plasmic reticulum (ER)-nucleus signal transduction pathway. En-
doplasmic reticulum stress is caused by the expression of NS5A.
This in turn initiates STAT-3 and NF-κB pathway. The mechanism
of ROS production initiates with the reduction of molecular oxygen,
to form unstable superoxide O2− reduces to a relatively stable hy-
drogen peroxide. Hydrogen peroxide is able to affect important cel-
lular molecules to produce more free radicals (hydroxyl radicals)
which enters the chain reaction [22–24]. Some major sources of
ROS are;Sources of ROSEnvironmental factors Mitochondrial factorsUV radiations Electron transport chain
Viruses like RNA virus (HCV NS5A) Oxidative deamination of organic
amines
Allergens and industrial chemicals (ER)-nucleus signal transduction
pathway
Increased ozone, cigarette smoke & smog –
Xenobiotic metabolism –On the other hand, cells have developed several protective mecha-
nisms to prevent radical formation or to detoxify radicals. This series
of reactions stop in two conditions. Either the substrates get depleted
and milieu becomes anaerobic or when chain is broken up by the anti-
oxidants. Antioxidants are found in foods or generated by the biological
system itself. In most of the cases the harmful effects of ROS are elimi-
nated by antioxidants. Antioxidants break the chain reaction of free rad-
icals. Generally found antioxidants include vitamin E, vitamin C, and
glutathione (GSH). In the case of viral liver diseases glutathione is a
powerful antioxidant. These compounds have several mechanisms of
action. For example, GSH can neutralize reactive oxygen radicals by
transferring hydrogen to the reactive molecules, thus creating a more
stable chemical structure [25,26]. But for the patients suffering from
RNA virus diseases, like HCV, the levels of GSH and GR were found to
be abnormal in plasma, epithelial ﬂuid as well as in blood. The extent
of depletion varies with the changes in severity, nature and duration
of virus in the body [27–29].
It is not only the antioxidants like glutathione and glutathione-
dependent enzymeswhose normal concentration is altered by hepatitis
C. The normal production and utilization of numerous essential
micronutrients and trace metal is also disturbed by hepatitis C virus.
These essential trace metals and micronutrients like zinc (Zn), copper
(Cu), iron (Fe) and selenium (Se) play an important role in different
liver physiological processes like enzymatic activities, redox status, in-
ﬂammation, immune response and protein structure and function [30]
. Selenium, in combination with alpha-lipoic acid and silymarin, has
caused noticeable improvements in chronic HCV patients by upgrading
the inﬂammatory response [31].
Essential micronutrients (Zn, Cu, Fe, and Se) might aggravate
liver disease in case of deﬁciency, imbalance, or toxicity. Although
the precise causes remain to be elucidated, there is evidence that
cytokines might alter the levels of serum trace elements in viral
hepatitis. It was reported that inﬂammatory cytokines are higher
in HCV-infected individuals and increased Cu levels might result
from inﬂammatory responses and they are directly related to the
pathology developed in the liver by HCV [32].
The objective of the present studywas to undertake in depth studies
on the mechanism of action of different antioxidant enzymes and
micronutrients (zinc, copper, iron, selenium) in the hepatitis C patients.
The main target was to uncover the relationship between different
micronutrients, antioxidant enzymes and hepatitis C virus by constantly
monitoring the variations in the studied parameters at different viral
load levels in genotype 3 HCV patients.2. Patients and methods
2.1. Subject selection
200 random patients (82 F, 118 M), under treatment of different
doctors from the start of treatment till the completion of therapy,
were enrolled in this study. All the patients were diagnosed with hepa-
titis C. The patients were excluded from the study if they were positive
for hepatitis B, other types of liver disease, renal diseases, diabetes
mellitus or any other malignancies.
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from the start of therapy up to 6 months to test the possibility of relaps-
ing. Noneof the subjects have received anymicronutrient supplementa-
tion for at least one year.
A hundred randomly selected individuals (50 F, 50 M) with the
mean age of 24 years were without any clinical history or serological
evidence of hepatitis, served as a healthy control group without any
liver disease. The individuals with any possible association of oxidative
stress due to the consumption of tobacco, alcohol or drugswere exclud-
ed from the study. Informed consent was taken from all the study
patients and healthy controls. The study protocol was approved by the
institution's human research committee.
2.2. Detection of HCV RNA
HCV RNAwas isolated using the Roche AMPLICOR®Hepatitis C Virus
(HCV) Test version 2.0. Detection of HCV RNA was done by using Light
Cycler 2.0 real-time PCR (Roche Applied Sciences, Germany) (1).
2.3. Viral load
After detection of viral RNA, serum HCV RNA was quantitatively
determined by AMPLICOR® HCV MONITOR™ (Roche Molecular Diag-
nostics) and expressed as a log 10 of copies of RNA per millimeter. A
higher viral load indicates a higher level of infectiousness. Themanufac-
turer instructions of the RNA kit were followed. This assay has a lower
limit of 100 IU ml−1. Quantitative PCR utilizes competitive RT-PCR
involving two simultaneous reactions and incorporating an internal
control. The target sequences chosen are generally in the conserved 5′
un-translated region of the HCV genome, which is important for sensi-
tivity, speciﬁcity and reproducibility [33]. The internal control is a syn-
thetic RNA molecule having the same primer recognition sequence as
the HCV target sequence. Intensity of ampliﬁcation of HCV RNA is then
compared to the internal standard of known concentration to deter-
mine the relative concentration of HCV. The detection limit of current
assays is as low as 100 copies/ml of viral RNA. The AMPLICOR Monitor
assay is a modiﬁed RT-PCR assay undertaken in one tube. It is therefore
simpler than conventional RT-PCR techniques and has a lower risk of
contamination. The assay can detect 103 to 106 copies of HCV RNA
per milliliter of patient serum. The accuracy of AMPLICOR Monitor
assay may slightly vary in determining viral load for patients having
different HCV genotypes. Within the reference range HCV RNA concen-
trations detected by the AMPLICOR assay correlated with PCR.
2.4. HCV genotyping
HCVgenotypingwas performedusing a Cuto Flour, ThirdWave Tech-
nology, USA. The third wave assay uses Cleavage Enzymes to recognize
and cleave speciﬁc structures formed by the addition of two oligonucle-
otides (an Invader Oliga and Primary Probe) to the nucleic acid.
2.5. Micronutrient determination
2.5.1. Sample preparation and digestion
Before analysis, all the glasswares were washed in diluted nitric acid
(10%) and rinsed. Standard solution (1000 μg l−1) of selenium, copper,
manganese, zinc and iron was obtained from Merck, Germany.
Digestion of the serum samplewas done according to the already re-
ported method by Safaralizadeh et al. [34,35]. According to which,
serum (1 ml) was transferred to a Teﬂon beaker for mineralization,
then 3 ml of HNO3/HClO4 (1:1 v/v) were added. The temperature of
the sample was then brought gradually to boiling on a hot plate until
fumes of HClO4 appeared. Samples were then heated according to the
following temperature/time scheme: 175 °C/60 min, 200 °C/60 min,
and ﬁnally 250 °C/60 min. The mixture was then heated according to
the following (temperature/time) scheme: 175 °C/60 min, 200 °C/60 min, and ﬁnally 250 °C for 60 min. The mixture was then left to
cool down to room temperature. Then 10 ml of (6 N) HCl was added
and the sample was heated again on the hot plate to 170 °C for 30 min.
2.5.2. Sample analysis
The digested serum samples were analyzed for the micronutrients
by using an atomic absorption spectrophotometer, model Analytic
Jena (Vario III).
2.5.3. Estimation of glutathione and its enzyme activity
Reduced glutathione was determined by themethod of Moron et al.
(1979) and glutathione peroxidase activity was measured by methods
of Aydin et al. [36–38]. GSH was measured by the method of Tietze
[39]. GSH reacts with Ellman's reagent (5,5-dithio bis (nitrobenzoic
acid) or DTNB) to produce a chromophore TNB with a maximal absor-
bance at 412 nmand oxidized glutathione GSSG. The amount of glutathi-
onemeasured represents the sumof reduced and oxidized glutathione in
the sample ([GSH]t = [GSH] + 2 × [GSSG]). The rate of absorbance
change (ΔA 412 nm/min) is made to be linear for the convenience and
consistence of measurement, and is linearly proportional to the total
concentration of GSH. The concentration of an unknown (sample) is de-
termined by calculating from the linear equation generated from several
standards of glutathione.
Glutathione peroxidase activity was measured by methods of Aydin
et al. Prepare reaction mixture with 50 mmol/L TRIS buffer (pH 7.6)
and add to it 1 mmol/L Na2EDTA + 2 mmol/L reduced glutathione +
0.2 mmol/L NADPH + 4 mmol/L sodium azide + 1000 U glutathione
reductase (1 U = 11 μg/ml). The chemicals involved reaction mixture
and 8.8 mmol/L of hydrogen peroxide. 20 μl of serum was added in a
test tube and then 980 μl of reaction mixture was added and then incu-
bated for 5 min at room temperature (37 °C). Reaction was started by
addition of 0.5 ml of 8.8 mmol/l hydrogen peroxide. Then decreased
absorbance was taken at 340 nm for 3 min, every 1 min.Y = 0.0167 X− 0.0098
X = Concentration of GR.
Y = absorbance of sample.
Glutathione was assayed according to the method of Tietze [39].
0.1 ml tissue homogenate of each group was taken in test tubes.
2.4 ml of 0.02 M EDTA was added in each test tube and kept in ice bath
for 10 min. Then 2.0 ml of dH2O (distilled water) was added in each test
tube. 0.5 ml 50% TCA was added and kept in ice bath for 10–15 min.
The mixture was centrifuged at 3000–3500 rpm for 10 min. 1.0 ml su-
pernatant was taken is separate tubes and added 2.0 ml 0.15 M Tris
HCl and 0.05 ml DTNB. The mixture was vortexed and absorbance was
taken after 2–3 min at 412 nm. The absorbance was compared with
standard curve generated by the known GSH level. The GSH will be
measured in μg/ml.
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In the present study HCV patients are divided into three major
groups according to their viral load levels. In the mild group, the range
of viral load was 200,000–1,000,000. The moderate group included the
patients with the viral load ranging from 1,000,000 to 5,000,000 and
the severe group has a range of 5,000,000–25,000,000.
The concentration of Cu, Se and Fe (Table: 1.1) was found to be sig-
niﬁcantly increased, with the increase in HCV RNA levels, as compared
to the control (P b 0.05). In the mild, moderate and severe HCV RNA
groups the mean of Cu was 96.4 mg/L, 102.2 mg/L and 106.3 mg/L re-
spectively. In the mild, moderate and severe HCV RNA groups the
mean of Fe was 103.3 μg/ml, 103.8 μg/ml and 101.9 μg/ml respectively.
In the mild, moderate and severe HCV RNA groups the mean of Se was
15.89 μg/ml, 12.87 μg/ml and 14.25 μg/ml, respectively.
On the other hand, the concentration of Mn (Table 1.1) was found to
be signiﬁcantly decreased in the mild group and it elevated in the mod-
erate and severe groups as compared to the control (P b 0.05). In the
mild, moderate and severe HCV RNA groups the mean of Mn was
7.26 mg/ml, 8.50 mg/ml and 9.61 mg/ml, respectively. The concentra-
tion of Zn was found to be decreased signiﬁcantly, as compared to the
control (P b 0.05). In the mild, moderate and severe HCV RNA groups
themean of Zn was 65.7 mg/L, 76.02 mg/L and 73.9 mg/L, respectively.
The serum concentrations of glutathione reductase (Table 1.2) were
found to be signiﬁcantly increasing with the increase in the levels of
HCV RNA (P b 0.05). In the mild, moderate and severe HCV RNA groupsTable 1.1
Serum concentrations of micronutrients (Zn, Fe, Mn, Se and Cu).
Parameter Healthy control Viral load of HCV patients
Mild (20,000–100,000 IU/ml) Mod
Zn (mg/l) 88.9 ± 3.33 65.7 ± 10.9 76.02
Fe (μg/ml) 71.4 ± 22.8 103.3 ± 12.3 103.8
Mn (mg/ml) 11.24 ± 0.925 7.26 ± 1.80 8.50
Se (μg/ml) 6.41 ± 1.7 15.89 ± 5.17 12.87
Cu (mg/L) 65.5 ± 20.01 96.4 ± 21.8 102.2
Table 1.2
Serum concentrations of glutathione and glutathione-dependent enzymes.
Parameter Healthy control Viral load of HCV patients
Mild (20,000–100,000 IU/ml) Mo
GR (μg/l) 5.88 ± 0.325 6.37 ± 0.126 6.4
GPx (μmol/ml) 8.15 ± 1.23 4. 72 ± 0.175 4.6
GSH (μg/ml) 10.3 ± 0.97 3.01 ± 0.824 1.8the mean of GR was 6.377 μg/L, 6.44 μg/L and 6.406 μg/L, respectively.
However, the serum concentration of GSH and GPx (Table 1.2) were
found to be signiﬁcantly depleting, with the increase in HCV RNA levels,
and as compared to the control (P b 0.05).
The study identiﬁed themutual correlation between the selected pa-
rameters by applying in two-tailed Pearson correlation matrix analysis,
Table 1.3. Copper is correlated with selenium (0.492**), iron (.365**),
GSH (− .418**) GR (.437**), and GPx (− .489**). Manganese showed a
signiﬁcant correlation with GR (.552**), GPx (−640**), copper
(.492**), iron (.518**) and GSH (.448**). Iron was signiﬁcantly correlat-
ed with GR (.552**), GPx (−640**), GSH (− .564**), Copper (.492**),
Selenium (.518**), Manganese (− .385**). Selenium showed a positive
correlation with copper (.492**), iron (.518**) and GR (.435**) and in-
verse relationship with GSH (− .429**) and GPx (− .463**). Zinc was
signiﬁcantly correlated with GR (− .330**), GPx (.439**) and GSH
(.492**).4. Discussion
Antioxidants like the glutathione family including glutathione,
glutathione peroxidase and glutathione reductase act as biological indi-
cators for the assessment of many liver abnormalities like hepatitis C
and HCC [39,40]. In a study it was found that in HCV patients excessive
mitochondrial ROS are produced and as a result of obvious undesired
changes in the redox status of the patients and the levels of GSH, GPX
are found [41].
Reduced levels of selenium in this study can also be explained by the
fact that selenium is used as a co-factor for glutathione peroxidase
enzyme [27]. In HCV patients reduced levels of Se-dependent GPX and
reduced antioxidative ability are linkedwith hepatitis C and the reduced
micronutrient levels [42].
The essential micronutrients (Zn, Cu, Fe, and Se) might aggravate
liver disease in case of deﬁciency, imbalance, or toxicity. Although the
precise causes remain to be elucidated, there is evidence that cytokines
might alter the levels of serum trace elements in viral hepatitis. It was
reported that inﬂammatory cytokines are higher in HCV-infected indi-
viduals and increased Cu levels might result from inﬂammatory re-
sponses and they are directly related to the pathology developed in
the liver [43]. In the present study, Table 1.1, the serum levels of essen-
tial micronutrients like copper, selenium and iron were found to be sig-
niﬁcantly elevated and manganese and zinc concentrations were
reduced in the present study. In patients with HCV there is an inverse
relation between total serum zinc concentration and serum copper,
and direct association with plasma levels of retinol-binding proteinSig.
erate (100,000–500,000 IU/ml) Severe (above 500,000 IU/ml)
± 18.05 73.9 ± 25.12 0.00
± 6.10 101.9 ± 10.4 0.00
± 2.49 9.61 ± 1.08 0.001
± 4.11 14.25 ± 3.47 0.00
± 17.1 106.3 ± 5.93 0.00
Sig.
derate (100,000–500,000 IU/ml) Severe (above 500,000 IU/ml)
1 ± 0.115 6.44 ± 0.208 0.00
8 ± 4.27 4.57 ± 0.06 0.00














Fig. 1.2. Comparison between HCV positive patients and controls.
Table 1.3
Pearson correlation matrix (2-tailed) between the studied parameters of HCV patients.
GR GPx Cu Zn Se Fe Mn GSH
GR 1 − .546** .437** − .330* .435** .552** − .403** − .680**
GPx 1 − .489** .439** − .463** − .640** .471** .809**
Cu 1 − .076 .492** .365** − .175 − .418**
Zn 1 − .244 − .176 .267* .412**
Se 1 .518** − .108 − .429**
Fe 1 − .385** − .564**
Mn 1 .448**
GSH 1
** Correlation is signiﬁcant at the 0.01 level (2-tailed).
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related to changes in the manner by which zinc is bound to serum pro-
teins, particularly albumin. Total serum copper concentrations are
found to be increased and this increase was accounted for entirely by
increases in the concentration of ceruloplasmin copper [44] (Fig. 1.2).
The present study, Table 1.3, also conﬁrmed this association between
zinc and copper and their altered concentrations in HCV patients
as compared to the healthy subjects. The irregular levels of these
micronutrients, signiﬁcantly reduced concentrations of plasma zinc
(Zn); higher copper (Cu), and iron (Fe), may increase oxidative stress
[38] and hence, they can be used as indicators of oxidative stress in
the HCV patients. (See Fig. 1.1.)
Excessive concentration of iron (Table 1.1) in the hepatitis C patients
is associated with the HCV and HCV induced ROS. Due to this RNA
virus, the levels of 8-hydroxydeoxy-guanosine, 8-OHdG, signiﬁcantly
increases and the levels of hepcidin lowers. The elevated levels of
8-OHdG and reduced hepcidin are responsible for the iron overload in
the hepatitis patients [45]. Altered iron metabolism in the hepatitis CFig. 1.1.Mechanism of correlation between antioxidants and micronutrients leadinpatients can be associated with the decline in catalase activity as it is
the cofactor of catalase (Fig. 1.2).
Due to hepatitis C virus, metabolism of zinc is disturbed (Table 1.1).
HCV resulted in impaired synthesis of albumin and decreased level of
serum zinc concentration [46]. Similarly, abnormal protein metabolism,
carbohydrate metabolic disturbances, abnormal serum levels of some
liver enzymes (Table 1.4) like glutamine alkaline transferase, glutamine
pyruvate transferase, alanine aminotransferase, and a decrease in he-
patic antitoxic role due to HCV are also responsible for abnormal zinc
metabolism [47].
In hepatitis C, due to oxidative stress, the levels of antioxidant
(vitamins), antioxidant enzyme GPx and ALT, AST, manganese, and
zinc decreased and GR, copper, selenium and iron increased. From theg to the reduced working abilities of antioxidant defense system due to HCV.
Table 1.4
HCV patients and healthy control characteristics at the baseline.
Characteristics Group A (patients)
n = 200
Group B (healthy individuals)
n = 100
Male 118 (59%) 50 (50%)
Mean age, years ± SD 36.1 ± 10.8 31 ± 9.8
Female 82 (41%) 50 (50%)
Mean age, years ± SD 37.1 ± 9.21 24 ± 9.76
ALT 78.4 ± 22.5 23.4 ± 5.69
AST 82.4 ± 20.44 26 ± 5.66
TB 0.7 ± 0.90 0.4 ± 0.185
HCV RNA level IU/ml 4.594E6 ± 9.28E6 –
HCV genotype 3 –
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ent micronutrients and antioxidants showed that in a biological system
there is a proper sequence of execution of events and these events are
interdependent on each other.
5. Conclusion
Oxidative stress is a common pathogenetic mechanism that is re-
sponsible for the initiation and progression of hepatic damage after
exposure to hepatitis C virus. We aimed to investigate the relation-
ship between viral load and micronutrients and glutathione and
glutathione-dependent enzymes as oxidative stress markers among
HCV genotype 3 patients and none of the subjects have received anymi-
cronutrient supplementation for at least one year. Consequently, we
achieved a high signiﬁcant correlation between the study parameters
and found it a reliable indicator of hepatic cellular injury in the hepatitis
C patients. So far, these parameters are hardly focused in clinical studies
to control oxidative stress and the patients are mostly treated to clear
the hepatitis C virus quantitatively as well as qualitatively. As there
was a strong association of the selected parameters with the onset
and progression of disease, they can be used as a successful therapeutic
biomarker to diagnose the status of infection. Thus, the use of these
markers will be the least expensive and signiﬁcantly reliable tool to
check the presence of hepatitis C and stage of the disease.
In conclusion, this study showed a signiﬁcant and positive associa-
tion between serum GSH, GPx, GR, copper, manganese, zinc, selenium,
iron levels and different levels of viral load in HCV patients of genotype
3. This association, in fact, has a strong impact on amodiﬁed immune re-
sponse, steatosis and ﬁbrosis, mitochondrial damage, altered protein
structure and function, activation of inﬂammatory cells, apoptosis and
necrosis in HCV patients.
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